Skip to main content

Newsroom

Catch up on the latest news from our data experts and find out how we’ve been helping our clients achieve their goals.

Filter

Excelra and AsedaSciences

Excelra and AsedaSciences® announce a strategic Co-Marketing Agreement to provide scientists with single, easy-to-use platform, for small molecule toxicity assessment

April 7, 2025
GOSTAR SAR Database

GOSTAR® SAR Database: Now Faster, Smarter, and More Efficient

April 7, 2025

Orogen Therapeutics Partners with Excelra for GOSTAR®

December 13, 2024
Excelra's great place to work

Excelra certified for third consecutive year – Great Place To Work

March 6, 2024

Excelra acquires BISC Global, creating an international bioinformatics powerhouse with an industry-leading platform and service offering

April 19, 2023

BISC Global receives half a million euros to develop ML-based suite for accelerated antibody discovery and design

January 31, 2023

Excelra partners with Patcore, Inc

September 21, 2022

Excelra Partners with HotSpot Therapeutics to Enhance Allosteric Drug Discovery Efforts

May 25, 2022

Excelra Makes Strategic Investment in Anlitiks, a Disruptive HEOR and RWE Technology-led Consulting Company

April 19, 2022

Excelra Announces Strategic Investment In ProofPilot, a Leading Software as a Service (SaaS) Clinical Trial Research Platform

April 4, 2022

X-Chem and Excelra’s GOSTAR® Join Forces to Advance Drug Discovery for Challenging Targets

February 9, 2022

XtalPi Partners with Excelra for GOSTAR® to Enhance its Intelligent Digital Drug Discovery and Development Platform

January 19, 2022

Silexon Partners with Excelra, Deploying GOSTAR® to Strengthen its AI-driven Drug Discovery and Biopharmaceutical Research Platform

December 1, 2021

Excelra Announces Addition of Sudip Nandy to its Board of Directors

October 19, 2021

Excelra launches a re-envisioned version of GOSTAR®

August 23, 2021

Cyclica to use Excelra’s GOSTAR® Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification

October 21, 2020

Interview with Anandbir Brar, Chief Executive Officer, Excelra | Headline Partner at D4 Global (Virtual Event)

October 14, 2020

BISC Global Awarded a Eurostars Grant for the development of a machine learning-based antigen discovery and T-cell epitope prediction software

October 8, 2020

BISC Global selected as Top 10 Bioinformatics Company by CIO Applications

September 20, 2020

Standigm Partners with Excelra for GOSTAR® to Enhance its AI-Driven Drug Discovery Process

September 15, 2020

Please fill the form

"*" indicates required fields

This will close in 0 seconds

What data do you need?

We'd love to hear from you! Please fill out the form and we'll get back to you as soon as possible.

"*" indicates required fields

Country*

This will close in 0 seconds

Request for demo - GOSTAR™ Small Molecule

We'd love to hear from you! Please fill out the form and we'll get back to you as soon as possible.

"*" indicates required fields

Country*

This will close in 0 seconds

Request for demo - GOSTAR™ TPD

We'd love to hear from you! Please fill out the form and we'll get back to you as soon as possible.

"*" indicates required fields

Country*

This will close in 0 seconds

Let's Connect - GOSTAR™ Large Molecules

We'd love to hear from you! Please fill out the form and we'll get back to you as soon as possible.

"*" indicates required fields

Country*

This will close in 0 seconds

Thank you for showing interest in the BioVisualizer™

Please help us with the following details, and you will receive the access to the platform on your email

"*" indicates required fields

Country*

This will close in 0 seconds

Download Whitepaper

We'd love to hear you liked the whitepaper! Please fill out the form and we'll mail you direct to your inbox.

"*" indicates required fields

Country*

This will close in 0 seconds

Online Pipeline Platform (OP2)

We'd love to hear from you! Please fill out the form and we'll get back to you as soon as possible.

"*" indicates required fields

Country*

This will close in 0 seconds